Your session is about to expire
← Back to Search
Metformin + mHealth for Pulmonary Arterial Hypertension
Study Summary
This trial is testing two interventions to see if they can improve insulin resistance in people with pulmonary artery hypertension. The primary endpoint is a 10% improvement in the distance the person can walk in six minutes, or an improvement in the person's functional class according to the World Health Organization.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My PAH medication has been the same for the last 3 months, except for one diuretic change.My lung function is good and my chest scans are normal.I have Type I diabetes.My kidney function is reduced, with an eGFR below 60 mL/min.I have been diagnosed with PAH due to unknown causes, genetics, or exposure to drugs/toxins.I have untreated thyroid issues.I have been diagnosed with cirrhosis before.I am unable to do normal activities because I use a wheelchair, walker, or have severe pain.We are not able to track certain activities like swimming, ice skating, using a stair master, or activities on wheels like biking or rollerblading.My PAH is not caused by genetics, drugs, or toxins.I am 18 years old or older.I can walk on my own without help.My heart condition allows me to perform daily activities with little to no difficulty.I've had my water pill dosage changed more than once in the last month.I have severe heart failure.
- Group 1: Metformin + mHealth Intervention
- Group 2: Placebo + mHealth Intervention
- Group 3: Placebo + Usual Care
- Group 4: Metformin + Usual Care
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the Metformin and mHealth Intervention combination a risk-free solution for patients?
"Despite no previous evidence of efficacy, the safety profile of Metformin + mHealth Intervention was rated a 2 due to some existing data indicating its security."
What objectives is this research endeavor attempting to accomplish?
"This clinical trial seeks to measure the efficacy of mHealth intervention or metformin in improving six minute walking distance and daily step count over a 12 week period. Secondary outcomes include an assessment of differences in participant characteristics including demographic information, current medication regimen, physical exam results, echocardiogram readings and laboratory values at baseline compared with those taken after completion of the treatment. Plasma Brain Natriuretic Peptide (BNP) will also be measured as it is a marker for myocardial stress which decreases with exercise training."
Is admission for participants currently available in this research program?
"According to clinicaltrials.gov, this research is still open for recruitment and has been regularly updated since it was first posted on August 23rd 2018. The most recent update occurred on June 27th 2022."
Has Metformin been combined with mobile health tools in past studies?
"Currently, 170 clinical trials studying the Metformin + mHealth Intervention are in operation. 43 of these investigations have progressed to Phase 3 and most them originate from Pittsburgh, Pennsylvania; though 1903 other medical sites are also conducting research into this therapy."
To what extent is participation in this medical experiment limited?
"Affirmative, the clinical trial remains open for enrollment. According to the data hosted on clinicialtrials.gov, this medical investigation was first posted on August 23rd 2018 and most recently updated on June 27th 2022; it is currently seeking 130 participants at a single location."
What conditions may be alleviated by the Metformin + mHealth Intervention combination?
"Metformin and a mHealth Intervention are two viable treatments for physical activity, type 1 diabetes mellitus, and diabetic ketoacidosis."
Share this study with friends
Copy Link
Messenger